© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Eprinomectin traces its roots to the larger avermectin family, whose discovery reshaped parasite control in livestock. Researchers at Merck took the groundwork laid by Satoshi Ōmura and William Campbell on avermectins and started tweaking the structure, aiming for a compound that offered strong effectiveness without the milk withholding period that proved costly for dairy farmers. After testing several analogs and combinations, they settled on eprinomectin, exploring various chemical modifications to reach a balance between safety, duration in animal tissues, and activity against nematodes and ectoparasites. It arrived on the market in the mid-1990s, right at a time when resistance against older drugs was climbing and the dairy sector needed new options. Looking back, it’s clear that eprinomectin’s development wasn’t just about chemistry; the pressure from evolving parasites and demand for high milk yields drove every research decision.
Eprinomectin serves as an endectocide, meaning it takes on both internal organisms, like roundworms, and external threats, such as lice and mites, all in one go. Formulators sell it mostly as a pour-on solution, though injectable and topical forms also fill specific gaps in the market. Farmers and veterinarians see its value in treating herds quickly, without losing time or product to milk or meat withdrawal periods. Its strong lipid solubility means the drug spreads well in the skin’s oils and holds steady there for weeks, giving extended protection in one single dose. Drug manufacturers adjust concentrations to suit cattle, goats, and other species, with each market bringing its own regulations on maximum residue levels and dosage.
Eprinomectin comes as a white or off-white crystalline powder, barely soluble in water but dissolving well in alcohols and ketone-based solvents. Its molecular formula—C50H75NO14—shows how closely it resembles other avermectins, though a unique eprinomectin side chain shields it from metabolic breakdown that would carry over into milk. With a molecular weight just shy of 1,000 g/mol, it’s a sizable structure, explaining its stability and low volatility. Its melting point sits around 155°C, and storage in tightly sealed containers away from direct sunlight keeps it stable for months, even under veterinary field conditions.
Manufacturers must follow strict guidelines for labeling, providing not just species-specific dosing but clear withdrawal times, storage instructions, and warnings about accidental ingestion or eye contact. Labels for eprinomectin pour-ons warn users to don gloves and avoid open wounds, as absorption through human skin could mimic the side effects seen in overdosed animals—lethargy, tremors, lack of coordination. Labels give potency in mg/mL, typically 5 mg/mL or 10 mg/mL, matching the concentrations used in pivotal efficacy and safety trials. Serial numbers, production sites, and expiration dates build trust with buyers, who know counterfeit or outdated drugs risk animal health.
Eprinomectin synthesis starts with a fermentation broth of Streptomyces avermitilis, yielding a mixture of avermectin B1 components. Chemists separate B1a and B1b fractions, then attach a 4'-epi-acetylamino group using reagents under controlled temperature and pressure to produce pure eprinomectin. Purification follows, removing byproducts and concentrating the compound before dissolving it in glycol-based carriers for pour-on products. Every batch runs through chromatographic purity checks and environmental safety screens, given the compound’s long half-life once applied to animals.
The core transformation that distinguishes eprinomectin involves introducing an acetylamino moiety at position 4'' of the avermectin skeleton. This subtle tweak lowers milk partitioning compared to other relatives like ivermectin. The manufacturing process calls for careful manipulation of reagents and protecting groups. Over-reduction or overheating risk destroying the bioactive macrocyclic lactone ring, so quality control at every stage grows critical. Attempts to create new analogs, aiming for improved resistance profiles, follow these same steps, altering side chains or stereochemistry to enhance potency or safety.
Pharmacologists and veterinarians may recognize eprinomectin under several other monikers on global markets. Common synonyms include 4’’-epi-acetylamino-4’’-deoxyavermectin B1 and MK-397. Commercial brands like Eprinex, Ivomec Eprinex, and various generics now fill veterinary catalogs in North America, Europe, Asia, and Latin America. Despite the changing names, the molecule and its benefits stay consistent, though formulation additives and carrier solvents might differ across brands.
Agencies such as the FDA, EMA, and Chinese MARA keep a spotlight on safety, inspecting production sites and requiring environmental assessments before granting marketing approval to eprinomectin. On-farm application draws a line between careful, gloved handling and reckless use that risks operator exposure and animal overdosing. Local guidelines ban the pour-on drug for species without established safety data, and some regions limit use to veterinarians with prescription authority. River and soil monitoring comes into play, with scientists tracking the drug’s breakdown in manure and its effects on dung beetle populations, flagging areas where runoff might build up over time.
Eprinomectin carves out its biggest role in cattle, both dairy and beef, providing a much-needed tool for herds in parasite hot spots. Its no-withdrawal interval stands as a game-changer, especially for high-output dairy farms that can’t afford downtime from milk sales. Vets use it to control seasonal burdens of gastrointestinal nematodes and biting flies, often choosing eprinomectin before calving or at key points in the parasite lifecycle. Some success stories appear with goats, sheep, and even zoo hoofstock, though off-label use brings risks if species-specific studies haven’t been done. Wildlife managers occasionally turn to eprinomectin in sanctuaries, but regulations on environmental impact lift more scrutiny there.
Research on eprinomectin never stands still. University and company labs constantly lay out new trials, pitting the compound against emerging parasite strains that resist older drugs like ivermectin or moxidectin. Molecular biologists study how nematodes shuffle their detoxification genes, tracing the slow crawl towards eprinomectin resistance. Pharmaceutical chemists tweak the molecule’s structure, running hundreds of analogs through animal tests, hoping for better coverage of cattle ticks or safety at higher doses. Trials in combination with other dewormers look for synergy or at least a way to rotate products and delay resistance. Large-scale field research also checks manure runoff, side effects across breeds, and any long-term build-up in farm soils.
Not all compounds with strong parasite-killing power prove safe for every animal, so eprinomectin’s toxicity profile saw deep investigation before release and remains under the microscope today. Acute dosing studies in rats and dogs showed central nervous system signs only at doses far above any used in cattle, building confidence in its therapeutic index. For years, toxicologists have watched for unexpected harm to birds, insects, and aquatic life downstream from farms, as traces of the compound stick around in manure and water. Toxicity in non-target species, such as dung beetles, tells farmers to avoid overuse and rotate pastures, dampening the risk of ecosystem upsets. Human health studies support safe use by milk consumers, but call for tight handling rules to keep operators safe during application.
Eprinomectin faces an uncertain future as resistance edges upward in regions of heavy use, echoing the stories that doomed older compounds. More research pivots toward integrated parasite management, cutting back on blanket deworming in favor of targeted, diagnostics-driven treatments. Drug researchers see potential in new formulations—long-acting injectables, smart pour-on systems, or blends with immune boosters to stretch out the useful life of eprinomectin. Regulatory agencies may tighten oversight as public concerns rise about residues in food and water. If the industry and research community commit to stewardship and innovation, eprinomectin could keep its place on farms for decades, supporting both animal health and global food production in a changing landscape.
Eprinomectin shows up on the radar of anyone caring for cattle, sheep, goats, or even cats. It’s a type of macrocyclic lactone, a class of compounds with solid track records for knocking out parasites. I remember the first time I saw a vet lean over a Holstein, ready to pour it down the animal’s back, explaining that parasites cost farmers more than most folks realize. Losing a few pounds of milk or beef here and there adds up across an entire dairy or feedlot. Lots of money spent on feed just slips away if the animals are carrying worms or lice.
Farmers and vets count on Eprinomectin for its ability to wipe out a wide range of pests: roundworms, lungworms, mange mites, lice, and grubs. Each of these parasites takes more than just blood—they sap energy, appetite, and growth. Cows scratch, lose hair, and even stand off feed, all thanks to these pests.
This drug steps in and breaks the cycle. Pour-on solutions let farmers treat entire herds with little stress for animals and people. Unlike some drugs, Eprinomectin doesn’t taint the animal’s milk or meat with long-lasting residues. That means dairy workers don’t face frustrating withdrawal days, watching milk go down the drain. I’ve seen farms where missing milk revenue for even a couple of days makes life a lot harder, so this single detail matters a lot.
There’s public concern about medicines in food, and people want to know if their milk or steak is safe. Eprinomectin has tackled this issue directly; its low milk residue profile gets regular checks through food safety regulators. The European Food Safety Authority and FDA have both looked at the data before approving it. Surveys and routine tests over the years back up its reputation. I’ve talked with large-scale dairies that appreciate the transparency—nobody wants a food safety scare traced back to their barn.
Anytime a product works well, it gets a lot of use. Parasites can start to develop resistance. It reminds me of how antibiotics lose effectiveness if people use them without enough care. Some livestock vets have noticed worms surviving despite regular treatments. This problem can spread fast between farms, especially in tight farming communities.
Rotating types of dewormers, accurate dosing (no rushing treatments), and checking parasite levels before treating have all given better long-term results. Farm advisers and vets have shifted their advice over the years, teaching families how to keep resistance at bay. Innovation—like new combinations with other drugs and slow-release treatments—offers hope for getting ahead of stubborn worms.
Eprinomectin’s place in animal health comes from its reliability. Healthier cattle lead to more productive farms. Sustainable use demands responsibility from everyone involved: manufacturers, veterinarians, and farmers. Education does most of the heavy lifting—teaching the next generation to value stewardship so that treatments like Eprinomectin keep making a difference.
Healthy herds mean safer, better food for everyone. In my experience, success in farming rarely comes from a single product, but using a tool like Eprinomectin wisely raised standards for parasite control and reminded us all that good health on the farm benefits the whole community.
Anyone who spends much time around livestock knows how much trouble parasites can cause. Skin raw from itching, animals losing weight, milk yield falling off—nobody has time for that. Out in the fields, the family running cattle or goats faces these problems every season. So, figuring out the most effective way to deal with nasty parasites becomes a top concern. Eprinomectin drew plenty of attention after people noticed it kicked parasites clear out of herds and flocks, and it left little residue in milk—a big deal for dairy producers who want to keep their products safe and marketable.
Most folks know eprinomectin as a pour-on treatment. That means grabbing a dosing gun, filling it with solution, and dribbling the stuff straight along the animal’s back. It soaks through the skin—no injections, no pills to force down an uncooperative throat. If you’ve ever tried holding down a jittery cow or fiery goat, you realize how important this method is. A pour-on lets one person treat a line of animals without the stress and risk that sometimes crop up with needles or oral drenches.
There’s also an injectable version. In some herds, especially in hard-to-treat cases, subcutaneous injections get the nod. This route gives more accuracy if dosage levels need extra control or if parasites have grown stubborn from years of exposure. It’s a bit more laborious—handling the syringe, making sure animals stand still, and keeping the site clean to avoid infection. While not everyone jumps at the chance to jab an animal with a needle, on occasion, it’s the right tool for complex cases.
Another form? Topical sprays. In smaller herds, or in places with tight alleyways where animals can’t crowd together, a spray pump often works. It’s not quite as precise as the pour-on, but it covers enough ground to knock back lice, mites, and ticks, especially when you hit outbreaks hard and early.
Dairy and meat producers need to watch medication residues, especially with drugs that could pass into milk or fat. Eprinomectin caught on mostly because it leaves barely any trace in milk. The World Health Organization considers it one of the safer drugs for treating dairy animals, and studies show milk from treated cows meets safety standards if used properly. In my own experience, talking with local farmers, there’s a constant pressure to keep up with regulators and consumer expectations—nobody wants the headlines that follow a failed residue test.
Still, reading labels matters. Overdosing shoots up costs, risks resistance, and puts animals at risk for toxicity. Underdosing lets parasites keep breeding stronger generations, cycling back more problems in a season or two. Veterinary guidance isn’t just a box to tick for compliance—it genuinely helps tailor treatments to a farm's size and animal mix.
Plenty of folks overlook the weather. Heavy rain right after a pour-on treatment can wash the medication off, leaving animals with less protection than they expected. In my own county, there’s always debate about the best time to treat livestock. Some folks jump at the first warm spell, only to see a spring rainstorm undo their work. Better timing can stretch every dollar in tight budgets.
Parasite resistance grows as a problem. You see stories across rural communities: medications lose punch as bugs adapt. The Food and Agriculture Organization flagged this years ago, urging folks to rotate treatments and combine strategies—better pasture rotation, culling heavily infested animals, and regular fecal egg counts to monitor trends.
Handling eprinomectin like any strong tool means respecting what it can do and what it can’t. Farms run on narrow margins, and solutions that save labor, keep animals healthier, and avoid costly recalls make a real difference. By staying alert to best practices, listening to veterinary voices, and adapting to changes in the land and market, producers keep eprinomectin effective and safe. For anyone in the barn or out on the range, it’s not just about killing off bugs—it’s about protecting herds, food supply, and livelihoods over the long stretch.
Farmers and veterinarians reach for eprinomectin because it tackles parasites in livestock without leaving much residue in food products. Ease of use and a promise of cleaner milk and meat make it popular in modern agriculture. I’ve watched neighbors rely on it for cattle, while pushback from certain quarters signals caution. As this antiparasitic pulls its weight on the farm, concerns about side effects stick around for good reason.
Reports about eprinomectin usually focus on large animals: cattle, sheep, goats. Skin reactions top the list—swelling, redness, or itching at the spot of application show up frequently. Such reactions don’t always seem dramatic, but a herd with persistent skin problems loses both comfort and productivity. Vets I’ve spoken to say this happens often enough after pour-on treatments that farmers watch for it. Appetite often drops for a few animals, sometimes tied to stomach upset. In rare cases, animals lose coordination or seem more lethargic after a dose.
European regulators remind us that overdosing can make things worse: jerky movements, muscle tremors, even trouble breathing if too much gets absorbed. Eprinomectin belongs to the macrocyclic lactones, a drug class that moves through fat and sticks around longer in some animals than others. That means newborns or animals already sick may take a bigger hit. Even though most side effects fade after a few days, consistent patterns deserve attention on both small and large-scale farms.
I’ve seen runoff from treated animals spark debate among local bee enthusiasts. Eprinomectin makes its way into manure, and that manure enters the soil. There’s evidence that dung beetles and other insects—the kind that keep pastures healthy—suffer harm from exposure. Long-term, this disrupts the cycle that turns waste into next season’s grass, and it’s not something people consider when reading a product label.
As for food safety, one of eprinomectin’s selling points has been its low risk of residue. Regulators require strict withdrawal periods, and studies support the claim that milk and meat remain safe if those guidelines are followed. Problems start when withdrawal times get ignored or dosing errors happen. In global agriculture, corners sometimes get cut, and that puts consumers at risk. Trust between producer and grocery shopper hinges on each step in that process working as promised.
Side effects sometimes raise bigger questions about overusing these powerful drugs. Veterinarians I trust prefer to weigh treatments carefully. Limiting doses, sticking to recommended schedules, and close observation of herds keep trouble from escalating. Keeping records makes it easier to spot patterns, so if a certain batch of animals seems sensitive, the next cycle can get adjusted. Training farm staff in safe handling matters too. Wearing gloves minimizes exposure, and avoiding accidental spills stops unnecessary health risks before they start.
Alternatives exist, but not every farm can switch overnight. Rotating pastures and improving sanitation go a long way in reducing parasite load. A veterinary relationship built on honesty helps keep things in check. Ultimately, making time for careful management—rather than rushing for the easy fix—leads to healthier animals and farms that hold the public’s trust.
Eprinomectin belongs to the avermectin family and has carved out a strong reputation among veterinarians and livestock managers. It tackles parasites like lice, mites, stomach worms, and lungworms in cattle, sheep, goats, and sometimes even pets. For folks managing dairy cows or goat herds, eprinomectin seems almost tailor-made for treating parasites without throwing a wrench in milk production schedules. Many medicines put milk withdrawal periods front and center, forcing tough choices between animal health and business income. Eprinomectin aims to solve that problem, but the safety question keeps echoing through barns and vet clinics across the world—can you actually use it with confidence on animals that are pregnant or in full lactation?
Unlike other parasite treatments, eprinomectin comes with the blessing of regulators in many countries for use in lactating dairy cows. The U.S. Food and Drug Administration (FDA), European Medicines Agency, and Canadian authorities have all cleared formulations like Eprinex for zero milk withdrawal, provided they’re used at labeled doses. The drug doesn't show up above trace limits in the milk, and consumers don’t face risk of residues in cheese, yogurt, or a cold glass of milk at breakfast. Peer-reviewed studies support this; the residue levels after treatment are so low, the tests struggle to find anything at all.
Pregnant animals bring another layer of worry for producers. Fortunately, studies involving cows and goats have demonstrated that eprinomectin doesn’t cause birth defects, harm unborn calves, or reduce fertility. More than one dairy vet has told me they’ve used it during all stages of pregnancy over the years, watched dozens of healthy births, and seen no pattern of loss or deformity. Still, drug guidelines encourage a little bit of caution—manufacturers note the importance of dosing at label rates. Too much of any antiparasitic drug can stress a metabolism already working overtime in milk or calf production.
Peer-reviewed research and formal approval only go so far. Daily life on dairy farms brings unpredictable factors. Dirty environments, missed feeding, dehydration, or heat stress each stress the animal’s system. Adding drugs—even the “safe” ones—risks tipping a delicate balance. I’ve watched a stressed-out dairy cow respond well to eprinomectin, then seen a different herd that broke out in health problems the same season. Some of that boils down to genetics, some to management, but it’s never one-size-fits-all.
Farmers who sweat the costs and stakes of every lactation cycle don’t need theory, they look for treatments that get the job done with no side effects. Eprinomectin, on the whole, stacks up well by that standard. Many large milk operations rely on it regularly, especially where roundworms or lice threaten herd performance. Some organic programs take a different view and push for herbal or biological solutions, mostly because consumer demand for “zero chemicals” outweighs science on these farms.
For anyone managing animal health, watching new drug developments should become a habit. Parasite resistance could alter the eprinomectin equation. Cases in Europe show resistance emerging in sheep flocks; using the drug on every lactating cow every season may not work forever. Rotating antiparasitics, maintaining detailed health records, and tailoring treatment plans—they become the real keys to safe and lasting use of any drug in lactating or pregnant livestock. The real solution blends trusted medicines, keen observation, and an honest look at what your livestock actually need to thrive. Trust but verify—a phrase that keeps herds healthy and farmers sleeping a little better at night.
Eprinomectin popped onto my radar during a visit to a family dairy. The local vet told me how this antiparasitic drug handles a stubborn roundworm infestation in the milking herd. Unlike some other dewormers, eprinomectin doesn’t leave behind residues in the milk. So, dairy farmers can treat lactating cows without tossing out hundreds of dollars’ worth of milk down the drain. That alone has saved lots of headaches across many operations.
Almost every story about eprinomectin focuses on cattle. The drug cleared regulatory hurdles for use in beef and dairy cows years ago, mainly because it provides wide coverage against internal and external parasites—think roundworms, lungworms, mites, lice, and horn flies. Since the compound doesn’t contaminate milk, it’s become a go-to for dairy producers fighting off parasitic threats to cow health and productivity. Keeping cows comfortable and healthy leads to better yield and fewer vet bills.
Next, goats get a mention. Goats can succumb to several parasites, and controlling these pests directly affects their health, weight, and even milk quality. Though not every country gives an official green light for goat use, vets often turn to eprinomectin when other dewormers fall short. Dosage calculations require special attention, and not every form is labeled for goats, which underscores the need for an experienced hand. In my own neighborhood, goat keepers have turned to this option in stubborn cases, supported by their local veterinarians, especially where regular dewormers have lost potency.
Sheep farmers often struggle with similar parasite pressure. In some places, eprinomectin has received approval for sheep, although more commonly off-label use happens under vet guidance. The tough truth about sheep is that parasites adapt quickly to drugs, so rotation and careful management remain essential. Experienced sheep farmers advocate integrating pasture rotation and fecal monitoring alongside these treatments to avoid resistance.
The story shifts outside farm animals with a bit more caution. Eprinomectin sometimes forms part of topical products used in cats for mite eradication, mainly ear mites. Vets sometimes recommend it for complicated infections when other drugs come up short. Dogs and horses, for the most part, stay off the official list. Horses have safer and more specifically formulated alternatives, and dogs face higher toxicity risks from avermectins.
Public trust hinges on careful drug use in food-producing animals. The zero milk withdrawal period for eprinomectin goes a long way toward building confidence that food reaches tables free from drug contamination. Despite that advantage, experts urge careful dosing, detailed record-keeping, and consulting veterinarians before reaching for any antiparasitic—especially since unmonitored use increases drug resistance. Across the country, veterinarians provide the critical link between sustainable parasite management and animal welfare.
Heavy reliance on eprinomectin signals a much broader fight against resistant parasites. Bringing in integrated pest management—using rotational grazing, targeted deworming, and lab monitoring—reduces overuse and keeps the tools effective for years to come. Education, support for producers, and honest communication by veterinarians remain key for good stewardship of medications like eprinomectin. Every treatment is a balance between the immediate needs of animals and the bigger goal of lasting food security.
| Names | |
| Preferred IUPAC name | (4''R)-4''-deoxy-4''-epiacetylaminoavermectin B1a |
| Other names |
EPM MK-397 Ivomec Eprinex Eprinomec |
| Pronunciation | /ˌɛprɪnoʊˈmɛktɪn/ |
| Identifiers | |
| CAS Number | 123997-26-2 |
| Beilstein Reference | 12863637 |
| ChEBI | CHEBI:9186 |
| ChEMBL | CHEMBL363294 |
| ChemSpider | 5362989 |
| DrugBank | DB11435 |
| ECHA InfoCard | ECHA InfoCard: 100.108.695 |
| EC Number | 262-515-9 |
| Gmelin Reference | 105398 |
| KEGG | C15419 |
| MeSH | D017995 |
| PubChem CID | 9832919 |
| RTECS number | RN990AV7GL |
| UNII | PD6H6RVF10 |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C49H75NO14 |
| Molar mass | 914.14 g/mol |
| Appearance | White to yellowish crystalline powder |
| Odor | Odorless |
| Density | 1.23 g/cm³ |
| Solubility in water | Insoluble |
| log P | 4.82 |
| Vapor pressure | Decomposes |
| Acidity (pKa) | ~12.6 |
| Basicity (pKb) | 3.4 |
| Magnetic susceptibility (χ) | -7.2×10⁻⁶ |
| Refractive index (nD) | 1.63 |
| Viscosity | Viscous liquid |
| Dipole moment | 5.92 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 320.5 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | QG01AA04 |
| Hazards | |
| Main hazards | May be fatal if swallowed and enters airways. Causes skin irritation. Suspected of damaging fertility or the unborn child. Toxic to aquatic life with long lasting effects. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS06,GHS08 |
| Signal word | Warning |
| Hazard statements | H360, H400, H410 |
| Precautionary statements | P264, P270, P273, P280, P302+P352, P305+P351+P338, P337+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | 2-2-0 |
| Flash point | Flash point: 12 °C |
| Lethal dose or concentration | LD50 (oral, rat): >2000 mg/kg |
| LD50 (median dose) | > 2000 mg/kg (rat, oral) |
| PEL (Permissible) | 0.5 mg/kg |
| REL (Recommended) | 0.2 mg/kg |
| Related compounds | |
| Related compounds |
Abamectin Doramectin Ivermectin Milbemycin oxime Selamectin |
